Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

The purpose of this work was to analyse the ability of p53 and thymidilate synthase (TS) primary tumour expression to retrospectively predict clinical response to chemotherapy and long-term prognosis in patients with advanced colorectal cancers homogeneously treated by methotrexate (MTX)-modulated–5...

Descripción completa

Detalles Bibliográficos
Autores principales: Paradiso, A, Simone, G, Petroni, S, Leone, B, Vallejo, C, Lacava, J, Romero, A, Machiavelli, M, Lena, M De, Allegra, C J, Johnston, P G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363320/
https://www.ncbi.nlm.nih.gov/pubmed/10682666
http://dx.doi.org/10.1054/bjoc.1999.0964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363320/
https://www.ncbi.nlm.nih.gov/pubmed/10682666
http://dx.doi.org/10.1054/bjoc.1999.0964

Ejemplares similares